4893 items matching your search terms.

The importance of incorporating human factors in the design and implementation of artificial intelligence for skin cancer diagnosis in the real world

Felmingham, C. M. Adler, N. R. Ge, Z. Morton, R. L. Janda, M. Mar, V. J.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2020     DOI:10.1007/s40257-020-00574-4

EXamining ouTcomEs in chroNic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort Study

Foote, C. Hockham, C. Sukkar, L. Campain, A. Kang, A. Young, T. Cass, A. Chow, C. K. Comino, E. Gallagher, M. Jan, S. Knight, J. Liu, B. McNamara, M. Peiris, D. Pollock, C. Sullivan, D. Wong, G. Zoungas, S. Rogers, K. Jun, M. Jardine, M.
JMIR RES PROTOC, 2020     DOI:10.2196/15646

Quality of life in patients with cervical cancer after open versus minimally invasive radical hysterectomy (LACC): a secondary outcome of a multicentre, randomised, open-label, phase 3, non-inferiority trial

Frumovitz, M. Obermair, A. Coleman, R. L. Pareja, R. Lopez, A. Ribero, R. Isla, D. Rendon, G. Bernadini, M. Q. Buda, A. Moretti-Marquez, R. Zevallos, A. Vieira, M. A. Zhu, T. Land, R. P. Nicklin, J. Asher, R. Robledo, K. P. Gebski, V. Ramirez, P. T.
LANCET ONCOLOGY, 2020     DOI:10.1016/S1470-2045(20)30081-4

Questioning statin therapy for older patients - Authors' reply

Fulcher, J. Keech, A. Simes, J. Baigent, C. Collins, R.
LANCET, 2020     DOI:10.1016/S0140-6736(19)33159-9

Second-line treatment of hepatocellular carcinoma after sorafenib: Characterizing treatments used over the past 10 years and real-world eligibility for cabozantinib, regorafenib, and ramucirumab

Fung, A. S. Tam, V. C. Meyers, D. E. Sim, H. W. Knox, J. J. Zaborska, V. Davies, J. Ko, Y. J. Batuyong, E. Samawi, H. Cheung, W. Y. Lee-Ying, R.
CANCER MED, 2020     DOI:10.1002/cam4.3116

Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): A pragmatic, open-label, 12-month, randomised controlled trial

Furler, J. O'Neal, D. Speight, J. Blackberry, I. Manski-Nankervis, J. A. Thuraisingam, S. de La Rue, K. Ginnivan, L. Doyle, R. Holmes-Truscott, E. Khunti, K. Dalziel, K. Chiang, J. Audehm, R. Kennedy, M. Clark, M. Jenkins, A. Lake, A. J. Januszewski, A. S. Catchpool, M. Liew, D. Clarke, P. Best, J.
LANCET DIABETES ENDOCRINOL, 2020     DOI:10.1016/S2213-8587(19)30385-7

Cognition after lowering LDL-cholesterol with evolocumab

Gencer, B. Mach, F. Guo, J. Im, K. Ruzza, A. Wang, H. Kurtz, C. E. Pedersen, T. R. Keech, A. C. Ott, B. R. Sabatine, M. S. Giugliano, R. P. Fourier Investigators
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020     DOI:10.1016/j.jacc.2020.03.039

Efficacy of evolocumab on cardiovascular outcomes in patients with recent myocardial infarction: A prespecified secondary analysis from the FOURIER trial

Gencer, B. Mach, F. Murphy, S. A. De Ferrari, G. M. Huber, K. Lewis, B. S. Ferreira, J. Kurtz, C. E. Wang, H. Honarpour, N. Keech, A. C. Sever, P. S. Pedersen, T. R. Sabatine, M. S. Giugliano, R. P.
JAMA CARDIOL, 2020     DOI:10.1001/jamacardio.2020.0882

Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials

Gencer, B. Marston, N. A. Im, K. Cannon, C. P. Sever, P. Keech, A. Braunwald, E. Giugliano, R. P. Sabatine, M. S.
LANCET, 2020     DOI:10.1016/S0140-6736(20)32332-1

Stroke prevention with the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) inhibitor evolocumab added to statin in high-risk patients with stable atherosclerosis

Giugliano, R. P. Pedersen, T. R. Saver, J. L. Sever, P. S. Keech, A. C. Bohula, E. A. Murphy, S. A. Wasserman, S. M. Honarpour, N. Wang, H. Lira Pineda, A. Sabatine, M. S. Fourier Investigators
STROKE, 2020     DOI:10.1161/STROKEAHA.119.027759

Day 1 to day 4 serum hCG change in predicting single-dose methotrexate treatment failure for tubal ectopic pregnancies

Goh, A. Karine, P. Kirby, A. Williams, C. Kapurubandara, S.
EUROPEAN JOURNAL OF OBSTETRICS, GYNECOLOGY, AND REPRODUCTIVE BIOLOGY, 2020     DOI:10.1016/j.ejogrb.2020.10.036

Nomogram for estimating overall survival in patients with metastatic pancreatic cancer

Goldstein, D. Von Hoff, D. D. Chiorean, E. G. Reni, M. Tabernero, J. Ramanathan, R. K. Botteman, M. Aly, A. Margunato-Debay, S. Lu, B. Louis, C. U. McGovern, D. Lee, C. K.
PANCREAS, 2020     DOI:10.1097/MPA.0000000000001563

Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial

Grimison, P. Mersiades, A. Kirby, A. Lintzeris, N. Morton, R. Haber, P. Olver, I. Walsh, A. McGregor, I. Cheung, Y. Tognela, A. Hahn, C. Briscoe, K. Aghmesheh, M. Fox, P. Abdi, E. Clarke, S. Della-Fiorentina, S. Shannon, J. Gedye, C. Begbie, S. Simes, J. Stockler, M.
ANNALS OF ONCOLOGY, 2020     DOI:10.1016/j.annonc.2020.07.020

Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: Results of the GLANCE Head and Neck study

Grunwald, V. Chirovsky, D. Cheung, W. Y. Bertolini, F. Ahn, M. J. Yang, M. H. Castro, G. Berrocal, A. Sjoquist, K. Kuyas, H. Auclair, V. Guillaume, X. Joo, S. Shah, R. Harrington, K. Glance Head and Neck Study Investigators
ORAL ONCOLOGY, 2020     DOI:10.1016/j.oraloncology.2019.104526

A comprehensive proteomic SWATH-MS workflow for profiling blood extracellular vesicles: a new avenue for glioma tumour surveillance

Hallal, S. Azimi, A. Wei, H. Ho, N. Lee, M. Y. T. Sim, H. W. Sy, J. Shivalingam, B. Buckland, M. E. Alexander-Kaufman, K. L.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020     DOI:10.3390/ijms21134754